James H. Woods - Publications

Affiliations: 
University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
behavioral pharmacology

334 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Gerak LR, Maguire DR, Woods JH, Husbands SM, Disney A, France CP. Reversal and prevention of the respiratory-depressant effects of heroin by the novel µ opioid receptor antagonist methocinnamox in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. PMID 30463875 DOI: 10.1124/jpet.118.253286  1
2018 Maguire DR, Gerak LR, Woods JH, Husbands SM, Disney A, France CP. Long-lasting effects of methocinnamox on heroin self-administration in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. PMID 30401680 DOI: 10.1124/jpet.118.252353  1
2016 Saccone PA, Lindsey AM, Koeppe RA, Zelenock KA, Shao X, Sherman P, Quesada CA, Woods JH, Scott PJ. Intranasal opioid administration in rhesus monkeys: PET imaging and antinociception. The Journal of Pharmacology and Experimental Therapeutics. PMID 27625351 DOI: 10.1124/jpet.116.235192  0.6
2016 Saccone PA, Zelenock KA, Linsdey AM, Sulima A, Rice KC, Prinssen EP, Wichmann J, Woods JH. Characterization of the discriminative stimulus effects of a NOP receptor agonist Ro 64-6198 in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. PMID 26801398 DOI: 10.1124/jpet.115.231134  0.6
2015 Bertz JW, Jackson EL, Barron DR, Woods JH. Effects of sex and remifentanil dose on rats' acquisition of responding for a remifentanil-conditioned reinforcer. Behavioural Pharmacology. PMID 26580131 DOI: 10.1097/FBP.0000000000000205  0.6
2015 Bertz JW, Chen J, Woods JH. Effects of pramipexole on the acquisition of responding with opioid-conditioned reinforcement in the rat. Psychopharmacology. 232: 209-21. PMID 24985891 DOI: 10.1007/s00213-014-3659-2  1
2014 Howell LL, Nye JA, Stehouwer JS, Voll RJ, Mun J, Narasimhan D, Nichols J, Sunahara R, Goodman MM, Carroll FI, Woods JH. A thermostable bacterial cocaine esterase rapidly eliminates cocaine from brain in nonhuman primates. Translational Psychiatry. 4: e407. PMID 24984194 DOI: 10.1038/tp.2014.48  1
2013 Kishioka S, Kiguchi N, Kobayashi Y, Yamamoto C, Saika F, Wakida N, Ko MC, Woods JH. Pharmacokinetic evidence for the long-lasting effect of nor-binaltorphimine, a potent kappa opioid receptor antagonist, in mice. Neuroscience Letters. 552: 98-102. PMID 23933210 DOI: 10.1016/j.neulet.2013.07.040  1
2013 Bertz JW, Woods JH. Acquisition of responding with a remifentanil-associated conditioned reinforcer in the rat. Psychopharmacology. 229: 235-43. PMID 23609770 DOI: 10.1007/s00213-013-3102-0  1
2013 Jutkiewicz EM, Rice KC, Carroll FI, Woods JH. Patterns of nicotinic receptor antagonism II: cardiovascular effects in rats. Drug and Alcohol Dependence. 131: 284-97. PMID 23333294 DOI: 10.1016/j.drugalcdep.2012.12.021  1
2013 Koffarnus MN, Woods JH. Individual differences in discount rate are associated with demand for self-administered cocaine, but not sucrose. Addiction Biology. 18: 8-18. PMID 21812874 DOI: 10.1111/j.1369-1600.2011.00361.x  1
2012 Moynihan HA, Derrick I, Broadbear JH, Greedy BM, Aceto MD, Harris LS, Purington LC, Thomas MP, Woods JH, Traynor JR, Husbands SM, Lewis JW. Fumaroylamino-4,5-epoxymorphinans and related opioids with irreversible μ opioid receptor antagonist effects. Journal of Medicinal Chemistry. 55: 9868-74. PMID 23043264 DOI: 10.1021/jm301096s  1
2012 Koffarnus MN, Collins GT, Rice KC, Chen J, Woods JH, Winger G. Self-administration of agonists selective for dopamine D2, D3, and D4 receptors by rhesus monkeys. Behavioural Pharmacology. 23: 331-8. PMID 22785383 DOI: 10.1097/FBP.0b013e3283564dbb  1
2012 Collins GT, Brim RL, Noon KR, Narasimhan D, Lukacs NW, Sunahara RK, Woods JH, Ko MC. Repeated administration of a mutant cocaine esterase: effects on plasma cocaine levels, cocaine-induced cardiovascular activity, and immune responses in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 342: 205-13. PMID 22518021 DOI: 10.1124/jpet.112.194639  1
2012 Lee TY, Park YS, Garcia GA, Sunahara RK, Woods JH, Yang VC. Cell permeable cocaine esterases constructed by chemical conjugation and genetic recombination. Molecular Pharmaceutics. 9: 1361-73. PMID 22404344 DOI: 10.1021/mp200623w  1
2012 Narasimhan D, Woods JH, Sunahara RK. Bacterial cocaine esterase: a protein-based therapy for cocaine overdose and addiction. Future Medicinal Chemistry. 4: 137-50. PMID 22300094 DOI: 10.4155/fmc.11.194  1
2012 Collins GT, Narasimhan D, Cunningham AR, Zaks ME, Nichols J, Ko MC, Sunahara RK, Woods JH. Long-lasting effects of a PEGylated mutant cocaine esterase (CocE) on the reinforcing and discriminative stimulus effects of cocaine in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 1092-103. PMID 21993206 DOI: 10.1038/npp.2011.226  1
2012 Brim RL, Noon KR, Collins GT, Stein A, Nichols J, Narasimhan D, Ko MC, Woods JH, Sunahara RK. The fate of bacterial cocaine esterase (CocE): an in vivo study of CocE-mediated cocaine hydrolysis, CocE pharmacokinetics, and CocE elimination. The Journal of Pharmacology and Experimental Therapeutics. 340: 83-95. PMID 21990608 DOI: 10.1124/jpet.111.186049  1
2012 Collins GT, Cunningham AR, Chen J, Wang S, Newman AH, Woods JH. Effects of pramipexole on the reinforcing effectiveness of stimuli that were previously paired with cocaine reinforcement in rats. Psychopharmacology. 219: 123-35. PMID 21701814 DOI: 10.1007/s00213-011-2382-5  1
2011 Chen J, Collins GT, Levant B, Woods J, Deschamps JR, Wang S. CJ-1639: A Potent and Highly Selective Dopamine D3 Receptor Full Agonist. Acs Medicinal Chemistry Letters. 2: 620-625. PMID 22125662 DOI: 10.1021/ml200100t  1
2011 Jimenez-Gomez C, Osentoski A, Woods JH. Pharmacological evaluation of the adequacy of marble burying as an animal model of compulsion and/or anxiety. Behavioural Pharmacology. 22: 711-3. PMID 21921841 DOI: 10.1097/FBP.0b013e32834afebe  1
2011 Narasimhan D, Collins GT, Nance MR, Nichols J, Edwald E, Chan J, Ko MC, Woods JH, Tesmer JJ, Sunahara RK. Subunit stabilization and polyethylene glycolation of cocaine esterase improves in vivo residence time. Molecular Pharmacology. 80: 1056-65. PMID 21890748 DOI: 10.1124/mol.111.074997  1
2011 Brim RL, Noon KR, Collins GT, Nichols J, Narasimhan D, Sunahara RK, Woods JH. The ability of bacterial cocaine esterase to hydrolyze cocaine metabolites and their simultaneous quantification using high-performance liquid chromatography-tandem mass spectrometry. Molecular Pharmacology. 80: 1119-27. PMID 21885621 DOI: 10.1124/mol.111.074534  1
2011 Brim RL, Noon KR, Nichols J, Narasimhan D, Woods JH, Sunahara RK. Evaluation of the hydrolytic activity of a long-acting mutant bacterial cocaine in the presence of commonly co-administered drugs. Drug and Alcohol Dependence. 119: 224-8. PMID 21775073 DOI: 10.1016/j.drugalcdep.2011.06.018  1
2011 Jutkiewicz EM, Brooks EA, Kynaston AD, Rice KC, Woods JH. Patterns of nicotinic receptor antagonism: nicotine discrimination studies. The Journal of Pharmacology and Experimental Therapeutics. 339: 194-202. PMID 21730011 DOI: 10.1124/jpet.111.182170  1
2011 Koffarnus MN, Newman AH, Grundt P, Rice KC, Woods JH. Effects of selective dopaminergic compounds on a delay-discounting task. Behavioural Pharmacology. 22: 300-11. PMID 21694584 DOI: 10.1097/FBP.0b013e3283473bcb  1
2011 Collins GT, Zaks ME, Cunningham AR, St Clair C, Nichols J, Narasimhan D, Ko MC, Sunahara RK, Woods JH. Effects of a long-acting mutant bacterial cocaine esterase on acute cocaine toxicity in rats. Drug and Alcohol Dependence. 118: 158-65. PMID 21481548 DOI: 10.1016/j.drugalcdep.2011.03.015  1
2011 Collins GT, Carey KA, Narasimhan D, Nichols J, Berlin AA, Lukacs NW, Sunahara RK, Woods JH, Ko MC. Amelioration of the cardiovascular effects of cocaine in rhesus monkeys by a long-acting mutant form of cocaine esterase. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 1047-59. PMID 21289605 DOI: 10.1038/npp.2010.242  1
2011 Collins GT, Truong YN, Levant B, Chen J, Wang S, Woods JH. Behavioral sensitization to cocaine in rats: evidence for temporal differences in dopamine D3 and D2 receptor sensitivity. Psychopharmacology. 215: 609-20. PMID 21207013 DOI: 10.1007/s00213-010-2154-7  1
2011 Jimenez-Gomez C, Winger G, Dean RL, Deaver DR, Woods JH. Naltrexone decreases D-amphetamine and ethanol self-administration in rhesus monkeys. Behavioural Pharmacology. 22: 87-90. PMID 21160425 DOI: 10.1097/FBP.0b013e3283423d55  1
2011 Xue L, Ko MC, Tong M, Yang W, Hou S, Fang L, Liu J, Zheng F, Woods JH, Tai HH, Zhan CG. Design, preparation, and characterization of high-activity mutants of human butyrylcholinesterase specific for detoxification of cocaine. Molecular Pharmacology. 79: 290-7. PMID 20971807 DOI: 10.1124/mol.110.068494  1
2011 Podlesnik CA, Ko MC, Winger G, Wichmann J, Prinssen EP, Woods JH. The effects of nociceptin/orphanin FQ receptor agonist Ro 64-6198 and diazepam on antinociception and remifentanil self-administration in rhesus monkeys. Psychopharmacology. 213: 53-60. PMID 20852848 DOI: 10.1007/s00213-010-2012-7  1
2011 Koek W, Woods JH, France CP. Obituary: Francis C. Colpaert, Ph.D. (1950-2010) Psychopharmacology. 1-2. DOI: 10.1007/s00213-011-2179-6  1
2010 Pichika R, Jewett DM, Sherman PS, Traynor JR, Husbands SM, Woods JH, Kilbourn MR. Synthesis and in vivo brain distribution of carbon-11-labeled δ-opioid receptor agonists. Nuclear Medicine and Biology. 37: 989-96. PMID 21055630 DOI: 10.1016/j.nucmedbio.2010.06.002  1
2010 Podlesnik CA, Jimenez-Gomez C, Woods JH. A choice procedure to assess the aversive effects of drugs in rodents. Journal of the Experimental Analysis of Behavior. 93: 203-23. PMID 20885811 DOI: 10.1901/jeab.2010.93-203  1
2010 Fantegrossi WE, Simoneau J, Cohen MS, Zimmerman SM, Henson CM, Rice KC, Woods JH. Interaction of 5-HT2A and 5-HT2C receptors in R(-)-2,5-dimethoxy-4-iodoamphetamine-elicited head twitch behavior in mice. The Journal of Pharmacology and Experimental Therapeutics. 335: 728-34. PMID 20858706 DOI: 10.1124/jpet.110.172247  1
2010 Cooper ZD, Shi YG, Woods JH. Reinforcer-dependent enhancement of operant responding in opioid-withdrawn rats. Psychopharmacology. 212: 369-78. PMID 20686752 DOI: 10.1007/s00213-010-1966-9  1
2010 Li SM, Collins GT, Paul NM, Grundt P, Newman AH, Xu M, Grandy DK, Woods JH, Katz JL. Yawning and locomotor behavior induced by dopamine receptor agonists in mice and rats. Behavioural Pharmacology. 21: 171-81. PMID 20463460 DOI: 10.1097/FBP.0b013e32833a5c68  1
2010 Narasimhan D, Nance MR, Gao D, Ko MC, Macdonald J, Tamburi P, Yoon D, Landry DM, Woods JH, Zhan CG, Tesmer JJ, Sunahara RK. Structural analysis of thermostabilizing mutations of cocaine esterase. Protein Engineering, Design & Selection : Peds. 23: 537-47. PMID 20436035 DOI: 10.1093/protein/gzq025  1
2010 Brim RL, Nance MR, Youngstrom DW, Narasimhan D, Zhan CG, Tesmer JJ, Sunahara RK, Woods JH. A thermally stable form of bacterial cocaine esterase: a potential therapeutic agent for treatment of cocaine abuse. Molecular Pharmacology. 77: 593-600. PMID 20086035 DOI: 10.1124/mol.109.060806  1
2010 Park JB, Kwon YM, Lee TY, Brim R, Ko MC, Sunahara RK, Woods JH, Yang VC. PEGylation of bacterial cocaine esterase for protection against protease digestion and immunogenicity. Journal of Controlled Release : Official Journal of the Controlled Release Society. 142: 174-9. PMID 19857534 DOI: 10.1016/j.jconrel.2009.10.015  1
2010 Wood SK, Narasimhan D, Cooper Z, Sunahara RK, Woods JH. Prevention and reversal by cocaine esterase of cocaine-induced cardiovascular effects in rats. Drug and Alcohol Dependence. 106: 219-29. PMID 19800183 DOI: 10.1016/j.drugalcdep.2009.09.001  1
2010 Jutkiewicz EM, Baladi MG, Cooper ZD, Woods JH. In reply Annals of Emergency Medicine. 55: 485-486. DOI: 10.1016/j.annemergmed.2009.11.028  1
2009 Nieland NP, Rennison D, Broadbear JH, Purington L, Woods JH, Traynor JR, Lewis JW, Husbands SM. 14beta-Arylpropiolylamino-17-cyclopropylmethyl-7,8-dihydronormorphinones and related opioids. Further examples of pseudoirreversible mu opioid receptor antagonists. Journal of Medicinal Chemistry. 52: 6926-30. PMID 19842669 DOI: 10.1021/jm901074a  1
2009 Collins GT, Brim RL, Narasimhan D, Ko MC, Sunahara RK, Zhan CG, Woods JH. Cocaine esterase prevents cocaine-induced toxicity and the ongoing intravenous self-administration of cocaine in rats. The Journal of Pharmacology and Experimental Therapeutics. 331: 445-55. PMID 19710369 DOI: 10.1124/jpet.108.150029  1
2009 Collins GT, Woods JH. Influence of conditioned reinforcement on the response-maintaining effects of quinpirole in rats. Behavioural Pharmacology. 20: 492-504. PMID 19696656 DOI: 10.1097/FBP.0b013e328330ad9b  1
2009 Ko MC, Woods JH, Fantegrossi WE, Galuska CM, Wichmann J, Prinssen EP. Behavioral effects of a synthetic agonist selective for nociceptin/orphanin FQ peptide receptors in monkeys. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 2088-96. PMID 19279568 DOI: 10.1038/npp.2009.33  1
2009 Moynihan H, Jales AR, Greedy BM, Rennison D, Broadbear JH, Purington L, Traynor JR, Woods JH, Lewis JW, Husbands SM. 14 beta-O-cinnamoylnaltrexone and related dihydrocodeinones are mu opioid receptor partial agonists with predominant antagonist activity. Journal of Medicinal Chemistry. 52: 1553-7. PMID 19253983 DOI: 10.1021/jm8012272  1
2009 Ko MC, Narasimhan D, Berlin AA, Lukacs NW, Sunahara RK, Woods JH. Effects of cocaine esterase following its repeated administration with cocaine in mice. Drug and Alcohol Dependence. 101: 202-9. PMID 19217723 DOI: 10.1016/j.drugalcdep.2009.01.002  1
2009 Collins GT, Truccone A, Haji-Abdi F, Newman AH, Grundt P, Rice KC, Husbands SM, Greedy BM, Enguehard-Gueiffier C, Gueiffier A, Chen J, Wang S, Katz JL, Grandy DK, Sunahara RK, ... Woods JH, et al. Proerectile effects of dopamine D2-like agonists are mediated by the D3 receptor in rats and mice. The Journal of Pharmacology and Experimental Therapeutics. 329: 210-7. PMID 19136638 DOI: 10.1124/jpet.108.144048  1
2009 Jutkiewicz EM, Baladi MG, Cooper ZD, Narasimhan D, Sunahara RK, Woods JH. A bacterial cocaine esterase protects against cocaine-induced epileptogenic activity and lethality. Annals of Emergency Medicine. 54: 409-20. PMID 19013687 DOI: 10.1016/j.annemergmed.2008.09.023  1
2009 Gao D, Narasimhan DL, Macdonald J, Brim R, Ko MC, Landry DW, Woods JH, Sunahara RK, Zhan CG. Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Molecular Pharmacology. 75: 318-23. PMID 18987161 DOI: 10.1124/mol.108.049486  1
2009 Koffarnus MN, Greedy B, Husbands SM, Grundt P, Newman AH, Woods JH. The discriminative stimulus effects of dopamine D2- and D3-preferring agonists in rats. Psychopharmacology. 203: 317-27. PMID 18807248 DOI: 10.1007/s00213-008-1323-4  1
2008 Collins GT, Woods JH. Narrowing in on compulsions: dopamine receptor functions. Experimental and Clinical Psychopharmacology. 16: 498-502. PMID 19086770 DOI: 10.1037/a0014190  1
2008 Chen J, Collins GT, Zhang J, Yang CY, Levant B, Woods J, Wang S. Design, synthesis, and evaluation of potent and selective ligands for the dopamine 3 (D3) receptor with a novel in vivo behavioral profile. Journal of Medicinal Chemistry. 51: 5905-8. PMID 18785726 DOI: 10.1021/jm800471h  1
2008 Zheng F, Yang W, Ko MC, Liu J, Cho H, Gao D, Tong M, Tai HH, Woods JH, Zhan CG. Most efficient cocaine hydrolase designed by virtual screening of transition states. Journal of the American Chemical Society. 130: 12148-55. PMID 18710224 DOI: 10.1021/ja803646t  1
2008 Cooper ZD, Truong YN, Shi YG, Woods JH. Morphine deprivation increases self-administration of the fast- and short-acting mu-opioid receptor agonist remifentanil in the rat. The Journal of Pharmacology and Experimental Therapeutics. 326: 920-9. PMID 18515643 DOI: 10.1124/jpet.108.139196  1
2008 Xie H, Woods JH, Traynor JR, Ko MC. The spinal antinociceptive effects of endomorphins in rats: behavioral and G protein functional studies. Anesthesia and Analgesia. 106: 1873-81. PMID 18499626 DOI: 10.1213/ane.0b013e31817300be  1
2008 Koffarnus MN, Woods JH. Quantification of drug choice with the generalized matching law in rhesus monkeys. Journal of the Experimental Analysis of Behavior. 89: 209-24. PMID 18422019 DOI: 10.1901/jeab.2008.89-209  1
2008 Pascoe JE, Williams KL, Mukhopadhyay P, Rice KC, Woods JH, Ko MC. Effects of mu, kappa, and delta opioid receptor agonists on the function of hypothalamic-pituitary-adrenal axis in monkeys. Psychoneuroendocrinology. 33: 478-86. PMID 18325678 DOI: 10.1016/j.psyneuen.2008.01.006  1
2008 Collins GT, Calinski DM, Newman AH, Grundt P, Woods JH. Food restriction alters N'-propyl-4,5,6,7-tetrahydrobenzothiazole-2,6-diamine dihydrochloride (pramipexole)-induced yawning, hypothermia, and locomotor activity in rats: evidence for sensitization of dopamine D2 receptor-mediated effects. The Journal of Pharmacology and Experimental Therapeutics. 325: 691-7. PMID 18305018 DOI: 10.1124/jpet.107.133181  1
2008 Fantegrossi WE, Ciullo JR, Wakabayashi KT, De La Garza R, Traynor JR, Woods JH. A comparison of the physiological, behavioral, neurochemical and microglial effects of methamphetamine and 3,4-methylenedioxymethamphetamine in the mouse. Neuroscience. 151: 533-43. PMID 18082974 DOI: 10.1016/j.neuroscience.2007.11.007  1
2008 Jutkiewicz EM, Baladi MG, Folk JE, Rice KC, Woods JH. The delta-opioid receptor agonist SNC80 [(+)-4-[alpha(R)-alpha-[(2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl]-(3-methoxybenzyl)-N,N-diethylbenzamide] synergistically enhances the locomotor-activating effects of some psychomotor stimulants, but not direct dopamine agonists, in rats. The Journal of Pharmacology and Experimental Therapeutics. 324: 714-24. PMID 17986650 DOI: 10.1124/jpet.107.123844  1
2008 Metcalf MD, Aceto MD, Harris LS, Woods JH, Traynor JR, Coop A, May EL. The influence of esters and carboxylic acids as the N-substituent of opioids. Part 1: Benzomorphans. Bioorganic & Medicinal Chemistry. 16: 869-73. PMID 17962026 DOI: 10.1016/j.bmc.2007.10.030  1
2007 Wood SK, Woods JH. Corticotropin-releasing factor receptor-1: a therapeutic target for cardiac autonomic disturbances. Expert Opinion On Therapeutic Targets. 11: 1401-13. PMID 18028006 DOI: 10.1517/14728222.11.11.1401  1
2007 Chadman KK, Woods JH, Stitzel J. Chlorisondamine inhibits the nicotine-induced stimulation of c-fos in the pigeon brain for up to 2 weeks. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 9: 927-36. PMID 17763108 DOI: 10.1080/14622200701540838  1
2007 Lee H, Naughton NN, Woods JH, Ko MC. Effects of butorphanol on morphine-induced itch and analgesia in primates. Anesthesiology. 107: 478-85. PMID 17721251 DOI: 10.1097/01.anes.0000278876.20263.a7  1
2007 Collins GT, Woods JH. Drug and reinforcement history as determinants of the response-maintaining effects of quinpirole in the rat. The Journal of Pharmacology and Experimental Therapeutics. 323: 599-605. PMID 17675585 DOI: 10.1124/jpet.107.123042  1
2007 Wade-Galuska T, Winger G, Woods JH. A behavioral economic analysis of cocaine and remifentanil self-administration in rhesus monkeys. Psychopharmacology. 194: 563-72. PMID 17628791 DOI: 10.1007/s00213-007-0858-0  1
2007 Zhang H, Shi YG, Woods JH, Watson SJ, Ko MC. Central kappa-opioid receptor-mediated antidepressant-like effects of nor-Binaltorphimine: behavioral and BDNF mRNA expression studies. European Journal of Pharmacology. 570: 89-96. PMID 17601558 DOI: 10.1016/j.ejphar.2007.05.045  1
2007 Collins GT, Newman AH, Grundt P, Rice KC, Husbands SM, Chauvignac C, Chen J, Wang S, Woods JH. Yawning and hypothermia in rats: effects of dopamine D3 and D2 agonists and antagonists. Psychopharmacology. 193: 159-70. PMID 17393143 DOI: 10.1007/s00213-007-0766-3  1
2007 Galuska CM, Wade-Galuska T, Woods JH, Winger G. Fixed-ratio schedules of cocaine self-administration in rhesus monkeys: joint control of responding by past and upcoming doses. Behavioural Pharmacology. 18: 171-5. PMID 17351424 DOI: 10.1097/FBP.0b013e3280d48073  1
2007 Ko MC, Bowen LD, Narasimhan D, Berlin AA, Lukacs NW, Sunahara RK, Cooper ZD, Woods JH. Cocaine esterase: interactions with cocaine and immune responses in mice. The Journal of Pharmacology and Experimental Therapeutics. 320: 926-33. PMID 17114567 DOI: 10.1124/jpet.106.114223  1
2007 Wade-Galuska T, Galuska CM, Winger G, Woods JH. Aspartame demand in rhesus monkeys: effects of volume and concentration manipulations. Behavioural Processes. 74: 71-8. PMID 17095168 DOI: 10.1016/j.beproc.2006.09.015  1
2006 Galuska CM, Winger G, Hursh SR, Woods JH. Assessing unit-price related remifentanil choice in rhesus monkeys. Journal of the Experimental Analysis of Behavior. 86: 181-95. PMID 17002226 DOI: 10.1901/jeab.2006.108.05  1
2006 Cooper ZD, Narasimhan D, Sunahara RK, Mierzejewski P, Jutkiewicz EM, Larsen NA, Wilson IA, Landry DW, Woods JH. Rapid and robust protection against cocaine-induced lethality in rats by the bacterial cocaine esterase. Molecular Pharmacology. 70: 1885-91. PMID 16968810 DOI: 10.1124/mol.106.025999  1
2006 Nieland NP, Moynihan HA, Carrington S, Broadbear J, Woods JH, Traynor JR, Husbands SM, Lewis JW. Structural determinants of opioid activity in derivatives of 14-aminomorphinones: effect of substitution in the aromatic ring of cinnamoylaminomorphinones and codeinones. Journal of Medicinal Chemistry. 49: 5333-8. PMID 16913723 DOI: 10.1021/jm0604777  1
2006 Ko MC, Wei H, Woods JH, Kennedy RT. Effects of intrathecally administered nociceptin/orphanin FQ in monkeys: behavioral and mass spectrometric studies. The Journal of Pharmacology and Experimental Therapeutics. 318: 1257-64. PMID 16766718 DOI: 10.1124/jpet.106.106120  1
2006 Wood SK, Verhoeven RE, Savit AZ, Rice KC, Fischbach PS, Woods JH. Facilitation of cardiac vagal activity by CRF-R1 antagonists during swim stress in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 2580-90. PMID 16710322 DOI: 10.1038/sj.npp.1301085  1
2006 Winger G, Galuska CM, Hursh SR, Woods JH. Relative reinforcing effects of cocaine, remifentanil, and their combination in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 318: 223-9. PMID 16571623 DOI: 10.1124/jpet.105.100461  1
2006 Jutkiewicz EM, Baladi MG, Folk JE, Rice KC, Woods JH. The convulsive and electroencephalographic changes produced by nonpeptidic delta-opioid agonists in rats: comparison with pentylenetetrazol. The Journal of Pharmacology and Experimental Therapeutics. 317: 1337-48. PMID 16537798 DOI: 10.1124/jpet.105.095810  1
2006 Zhang H, Torregrossa MM, Jutkiewicz EM, Shi YG, Rice KC, Woods JH, Watson SJ, Ko MC. Endogenous opioids upregulate brain-derived neurotrophic factor mRNA through delta- and micro-opioid receptors independent of antidepressant-like effects. The European Journal of Neuroscience. 23: 984-94. PMID 16519663 DOI: 10.1111/j.1460-9568.2006.04621.x  1
2006 Fantegrossi WE, Harrington AW, Kiessel CL, Eckler JR, Rabin RA, Winter JC, Coop A, Rice KC, Woods JH. Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats. Pharmacology, Biochemistry, and Behavior. 83: 122-9. PMID 16460788 DOI: 10.1016/j.pbb.2005.12.015  1
2006 Jutkiewicz EM, Torregrossa MM, Sobczyk-Kojiro K, Mosberg HI, Folk JE, Rice KC, Watson SJ, Woods JH. Behavioral and neurobiological effects of the enkephalinase inhibitor RB101 relative to its antidepressant effects. European Journal of Pharmacology. 531: 151-9. PMID 16442521 DOI: 10.1016/j.ejphar.2005.12.002  1
2006 Torregrossa MM, Jutkiewicz EM, Mosberg HI, Balboni G, Watson SJ, Woods JH. Peptidic delta opioid receptor agonists produce antidepressant-like effects in the forced swim test and regulate BDNF mRNA expression in rats. Brain Research. 1069: 172-81. PMID 16364263 DOI: 10.1016/j.brainres.2005.11.005  1
2006 Ko MC, Divin MF, Lee H, Woods JH, Traynor JR. Differential in vivo potencies of naltrexone and 6beta-naltrexol in the monkey. The Journal of Pharmacology and Experimental Therapeutics. 316: 772-9. PMID 16258020 DOI: 10.1124/jpet.105.094409  1
2005 Lockridge O, Schopfer LM, Winger G, Woods JH. LARGE SCALE PURIFICATION OF BUTYRYLCHOLINESTERASE FROM HUMAN PLASMA SUITABLE FOR INJECTION INTO MONKEYS; A POTENTIAL NEW THERAPEUTIC FOR PROTECTION AGAINST COCAINE AND NERVE AGENT TOXICITY. The Journal of Medical, Chemical, Biological, and Radiological Defense. 3: nihms5095. PMID 16788731 DOI: 10.1901/jaba.2005.3-nihms5095  0.84
2005 Winger G, Woods JH, Galuska CM, Wade-Galuska T. Behavioral perspectives on the neuroscience of drug addiction. Journal of the Experimental Analysis of Behavior. 84: 667-81. PMID 16596985 DOI: 10.1901/jeab.2005.101-04  1
2005 Fantegrossi WE, Kugle KM, Valdes LJ, Koreeda M, Woods JH. Kappa-opioid receptor-mediated effects of the plant-derived hallucinogen, salvinorin A, on inverted screen performance in the mouse. Behavioural Pharmacology. 16: 627-33. PMID 16286814  1
2005 Galuska CM, Woods JH. Acquisition of cocaine self-administration with unsignaled delayed reinforcement in rhesus monkeys. Journal of the Experimental Analysis of Behavior. 84: 269-80. PMID 16262189 DOI: 10.1901/jeab.2005.99-04  1
2005 Torregrossa MM, Folk JE, Rice KC, Watson SJ, Woods JH. Chronic administration of the delta opioid receptor agonist (+)BW373U86 and antidepressants on behavior in the forced swim test and BDNF mRNA expression in rats. Psychopharmacology. 183: 31-40. PMID 16220339 DOI: 10.1007/s00213-005-0113-5  1
2005 Jutkiewicz EM, Rice KC, Traynor JR, Woods JH. Separation of the convulsions and antidepressant-like effects produced by the delta-opioid agonist SNC80 in rats. Psychopharmacology. 182: 588-96. PMID 16163520 DOI: 10.1007/s00213-005-0138-9  1
2005 Jutkiewicz EM, Kaminsky ST, Rice KC, Traynor JR, Woods JH. Differential behavioral tolerance to the delta-opioid agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in Sprague-Dawley rats. The Journal of Pharmacology and Experimental Therapeutics. 315: 414-22. PMID 16014751 DOI: 10.1124/jpet.105.088831  1
2005 Fantegrossi WE, Kiessel CL, De la Garza R, Woods JH. Serotonin synthesis inhibition reveals distinct mechanisms of action for MDMA and its enantiomers in the mouse. Psychopharmacology. 181: 529-36. PMID 15983787 DOI: 10.1007/s00213-005-0005-8  1
2005 Fantegrossi WE, Harrington AW, Eckler JR, Arshad S, Rabin RA, Winter JC, Coop A, Rice KC, Woods JH. Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats. Psychopharmacology. 181: 496-503. PMID 15983786 DOI: 10.1007/s00213-005-0009-4  1
2005 Collins GT, Witkin JM, Newman AH, Svensson KA, Grundt P, Cao J, Woods JH. Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior. The Journal of Pharmacology and Experimental Therapeutics. 314: 310-9. PMID 15833897 DOI: 10.1124/jpet.105.085472  1
2005 Husbands SM, Neilan CL, Broadbear J, Grundt P, Breeden S, Aceto MD, Woods JH, Lewis JW, Traynor JR. BU74, a complex oripavine derivative with potent kappa opioid receptor agonism and delayed opioid antagonism. European Journal of Pharmacology. 509: 117-25. PMID 15733546 DOI: 10.1016/j.ejphar.2004.12.035  1
2005 Hursh SR, Galuska CM, Winger G, Woods JH. The economics of drug abuse: a quantitative assessment of drug demand. Molecular Interventions. 5: 20-8. PMID 15731502 DOI: 10.1124/mi.5.1.6  1
2005 Jutkiewicz EM, Wood SK, Houshyar H, Hsin LW, Rice KC, Woods JH. The effects of CRF antagonists, antalarmin, CP154,526, LWH234, and R121919, in the forced swim test and on swim-induced increases in adrenocorticotropin in rats. Psychopharmacology. 180: 215-23. PMID 15696320 DOI: 10.1007/s00213-005-2164-z  1
2005 Fantegrossi WE, Ko MC, Woods JH, Richelson E. Antinociceptive, hypothermic, hypotensive, and reinforcing effects of a novel neurotensin receptor agonist, NT69L, in rhesus monkeys. Pharmacology, Biochemistry, and Behavior. 80: 341-9. PMID 15680187 DOI: 10.1016/j.pbb.2004.12.005  1
2005 Fantegrossi WE, Winger G, Woods JH, Woolverton WL, Coop A. Reinforcing and discriminative stimulus effects of 1-benzylpiperazine and trifluoromethylphenylpiperazine in rhesus monkeys. Drug and Alcohol Dependence. 77: 161-8. PMID 15664717 DOI: 10.1016/j.drugalcdep.2004.07.014  1
2005 Jutkiewicz EM, Walker NP, Folk JE, Rice KC, Portoghese PS, Woods JH, Traynor JR. Comparison of peptidic and nonpeptidic delta-opioid agonists on guanosine 5'-O-(3-[35S]thio)triphosphate ([35S]GTPgammaS) binding in brain slices from Sprague-Dawley rats. The Journal of Pharmacology and Experimental Therapeutics. 312: 1314-20. PMID 15574687 DOI: 10.1124/jpet.104.078741  1
2005 Broadbear JH, Winger G, Woods JH. Self-administration of methohexital, midazolam and ethanol: effects on the pituitary-adrenal axis in rhesus monkeys. Psychopharmacology. 178: 83-91. PMID 15322724 DOI: 10.1007/s00213-004-1986-4  1
2004 Parrott AC, Fantegrossi WE, Woods JH, Winger G, Kilbourn M, Sherman P, Woolverton WL, Yuan J, Hatzidimitriou G, Ricaurte GA. MDMA and the loss of reinforcement in Fantegrossi et al (2004) (multiple letters) Neuropsychopharmacology. 29: 1940-1942. PMID 15383828 DOI: 10.1038/sj.npp.1300538  1
2004 Neilan CL, Husbands SM, Breeden S, Ko MC, Aceto MD, Lewis JW, Woods JH, Traynor JR. Characterization of the complex morphinan derivative BU72 as a high efficacy, long-lasting mu-opioid receptor agonist. European Journal of Pharmacology. 499: 107-16. PMID 15363957 DOI: 10.1016/j.ejphar.2004.07.097  1
2004 Wei H, Nolkrantz K, Powell DH, Woods JH, Ko MC, Kennedy RT. Electrospray sample deposition for matrix-assisted laser desorption/ionization (MALDI) and atmospheric pressure MALDI mass spectrometry with attomole detection limits. Rapid Communications in Mass Spectrometry : Rcm. 18: 1193-200. PMID 15164348 DOI: 10.1002/rcm.1458  1
2004 Broadbear JH, Winger G, Woods JH. Self-administration of fentanyl, cocaine and ketamine: effects on the pituitary-adrenal axis in rhesus monkeys. Psychopharmacology. 176: 398-406. PMID 15114434 DOI: 10.1007/s00213-004-1891-x  1
2004 Williams KL, Broadbear JH, Woods JH. Noncontingent and response-contingent intravenous ethanol attenuates the effect of naltrexone on hypothalamic-pituitary-adrenal activity in rhesus monkeys. Alcoholism, Clinical and Experimental Research. 28: 566-71. PMID 15100607 DOI: 10.1097/01.ALC.0000121655.48922.C4  1
2004 Fantegrossi WE, Woods JH, Winger G. Transient reinforcing effects of phenylisopropylamine and indolealkylamine hallucinogens in rhesus monkeys. Behavioural Pharmacology. 15: 149-57. PMID 15096915 DOI: 10.1097/00008877-200403000-00007  1
2004 Mendelson WB, Roth T, Cassella J, Roehrs T, Walsh JK, Woods JH, Buysse DJ, Meyer RE. The treatment of chronic insomnia: drug indications, chronic use and abuse liability. Summary of a 2001 New Clinical Drug Evaluation Unit meeting symposium. Sleep Medicine Reviews. 8: 7-17. PMID 15062207 DOI: 10.1016/S1087-0792(03)00042-X  1
2004 Fantegrossi WE, Woolverton WL, Kilbourn M, Sherman P, Yuan J, Hatzidimitriou G, Ricaurte GA, Woods JH, Winger G. Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 1270-81. PMID 15039771 DOI: 10.1038/sj.npp.1300442  1
2004 Broadbear JH, Winger G, Rivier JE, Rice KC, Woods JH. Corticotropin-releasing hormone antagonists, astressin B and antalarmin: differing profiles of activity in rhesus monkeys. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 1112-21. PMID 14997174 DOI: 10.1038/sj.npp.1300410  1
2004 Fantegrossi WE, Kiessel CL, Leach PT, Van Martin C, Karabenick RL, Chen X, Ohizumi Y, Ullrich T, Rice KC, Woods JH. Nantenine: an antagonist of the behavioral and physiological effects of MDMA in mice. Psychopharmacology. 173: 270-7. PMID 14740148 DOI: 10.1007/s00213-003-1741-2  1
2004 Jutkiewicz EM, Eller EB, Folk JE, Rice KC, Traynor JR, Woods JH. Delta-opioid agonists: differential efficacy and potency of SNC80, its 3-OH (SNC86) and 3-desoxy (SNC162) derivatives in Sprague-Dawley rats. The Journal of Pharmacology and Experimental Therapeutics. 309: 173-81. PMID 14722329 DOI: 10.1124/jpet.103.061242  1
2004 Torregrossa MM, Isgor C, Folk JE, Rice KC, Watson SJ, Woods JH. The delta-opioid receptor agonist (+)BW373U86 regulates BDNF mRNA expression in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 649-59. PMID 14647482 DOI: 10.1038/sj.npp.1300345  1
2004 Chadman KK, Woods JH. Cardiovascular effects of nicotine, chlorisondamine, and mecamylamine in the pigeon. The Journal of Pharmacology and Experimental Therapeutics. 308: 73-8. PMID 14566012 DOI: 10.1124/jpet.103.057307  1
2003 Jutkiewicz EM, Rice KC, Woods JH, Winsauer PJ. Effects of the delta-opioid receptor agonist SNC80 on learning relative to its antidepressant-like effects in rats. Behavioural Pharmacology. 14: 509-16. PMID 14557718 DOI: 10.1097/01.fbp.0000095080.80017.9d  1
2003 Lee H, Naughton NN, Woods JH, Ko MC. Characterization of scratching responses in rats following centrally administered morphine or bombesin. Behavioural Pharmacology. 14: 501-8. PMID 14557717 DOI: 10.1097/01.fbp.0000095082.80017.0f  1
2003 Ko MC, Willmont KJ, Lee H, Flory GS, Woods JH. Ultra-long antagonism of kappa opioid agonist-induced diuresis by intracisternal nor-binaltorphimine in monkeys. Brain Research. 982: 38-44. PMID 12915238 DOI: 10.1016/S0006-8993(03)02938-X  1
2003 Greenwald MK, Johanson CE, Moody DE, Woods JH, Kilbourn MR, Koeppe RA, Schuster CR, Zubieta JK. Effects of buprenorphine maintenance dose on mu-opioid receptor availability, plasma concentrations, and antagonist blockade in heroin-dependent volunteers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 2000-9. PMID 12902992 DOI: 10.1038/sj.npp.1300251  1
2003 Sellers EM, Chilcoat HD, Gorodetzky CW, Reidenberg MM, Strain EC, Woods JH, Zacny JP, Henningfield JE, Johanson CE. Abuse liability assessment of CNS drugs: Conclusions, recommendations, and research priorities Drug and Alcohol Dependence. 70: S107-S114. PMID 12759201 DOI: 10.1016/S0376-8716(03)00103-0  1
2003 Greiner E, Spetea M, Krassnig R, Schüllner F, Aceto M, Harris LS, Traynor JR, Woods JH, Coop A, Schmidhammer H. Synthesis and biological evaluation of 14-alkoxymorphinans. 18. N-substituted 14-phenylpropyloxymorphinan-6-ones with unanticipated agonist properties: extending the scope of common structure-activity relationships. Journal of Medicinal Chemistry. 46: 1758-63. PMID 12699394 DOI: 10.1021/jm021118o  1
2003 Williams KL, Ko MC, Rice KC, Woods JH. Effect of opioid receptor antagonists on hypothalamic-pituitary-adrenal activity in rhesus monkeys. Psychoneuroendocrinology. 28: 513-28. PMID 12689609 DOI: 10.1016/S0306-4530(02)00037-9  1
2003 Ko MC, Lee H, Harrison C, Clark MJ, Song HF, Naughton NN, Woods JH, Traynor JR. Studies of micro-, kappa-, and delta-opioid receptor density and G protein activation in the cortex and thalamus of monkeys. The Journal of Pharmacology and Experimental Therapeutics. 306: 179-86. PMID 12676881 DOI: 10.1124/jpet.103.050625  1
2003 Ko MC, Lee H, Song MS, Sobczyk-Kojiro K, Mosberg HI, Kishioka S, Woods JH, Naughton NN. Activation of kappa-opioid receptors inhibits pruritus evoked by subcutaneous or intrathecal administration of morphine in monkeys. The Journal of Pharmacology and Experimental Therapeutics. 305: 173-9. PMID 12649366 DOI: 10.1124/jpet.102.044909  1
2003 Fantegrossi WE, Godlewski T, Karabenick RL, Stephens JM, Ullrich T, Rice KC, Woods JH. Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice. Psychopharmacology. 166: 202-11. PMID 12563544 DOI: 10.1007/s00213-002-1261-5  1
2003 Flory GS, Woods JH. The ascending limb of the cocaine dose-response curve for reinforcing effect in rhesus monkeys. Psychopharmacology. 166: 91-4. PMID 12529810 DOI: 10.1007/s00213-002-1336-3  1
2003 May EL, Coop A, Woods JH, Aceto MD, Bowman ER, Harris LS, Traynor JR. N-(trifluoromethyl)benzyl substituted N-normetazocines and N-norketobemidones. Bioorganic & Medicinal Chemistry. 11: 31-3. PMID 12467704 DOI: 10.1016/S0968-0896(02)00435-2  1
2002 Broadbear JH, Winger G, Rice KC, Woods JH. Antalarmin, a putative CRH-RI antagonist, has transient reinforcing effects in rhesus monkeys. Psychopharmacology. 164: 268-76. PMID 12424550 DOI: 10.1007/s00213-002-1187-y  1
2002 Broom DC, Jutkiewicz EM, Rice KC, Traynor JR, Woods JH. Behavioral effects of delta-opioid receptor agonists: potential antidepressants? Japanese Journal of Pharmacology. 90: 1-6. PMID 12396021 DOI: 10.1254/jjp.90.1  1
2002 Broom DC, Nitsche JF, Pintar JE, Rice KC, Woods JH, Traynor JR. Comparison of receptor mechanisms and efficacy requirements for delta-agonist-induced convulsive activity and antinociception in mice. The Journal of Pharmacology and Experimental Therapeutics. 303: 723-9. PMID 12388657 DOI: 10.1124/jpet.102.036525  1
2002 Woods JH, France CP. Determinants of the behavioral effects of opioids and their antagonists: contributions of the Laboratory of Psychobiology. Psychopharmacology. 163: 406-11. PMID 12373441 DOI: 10.1007/s00213-002-1212-1  1
2002 Woods JH, Winger GD. Observing responses maintained by stimuli associated with cocaine or remifentanil reinforcement in rhesus monkeys. Psychopharmacology. 163: 345-51. PMID 12373435 DOI: 10.1007/s00213-002-1201-4  1
2002 Broom DC, Jutkiewicz EM, Folk JE, Traynor JR, Rice KC, Woods JH. Convulsant activity of a non-peptidic delta-opioid receptor agonist is not required for its antidepressant-like effects in Sprague-Dawley rats. Psychopharmacology. 164: 42-8. PMID 12373418 DOI: 10.1007/s00213-002-1179-y  1
2002 Fantegrossi WE, Ullrich T, Rice KC, Woods JH, Winger G. 3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement. Psychopharmacology. 161: 356-64. PMID 12073162 DOI: 10.1007/s00213-002-1021-6  1
2002 Koetzner L, Woods JH. Characterization of equine butyrylcholinesterase disposition in the mouse. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 30: 724-30. PMID 12019201 DOI: 10.1124/dmd.30.6.724  1
2002 Koetzner L, Woods JH. Characterization of butyrylcholinesterase antagonism of cocaine-induced hyperactivity. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 30: 716-23. PMID 12019200 DOI: 10.1124/dmd.30.6.716  1
2002 Broom DC, Jutkiewicz EM, Folk JE, Traynor JR, Rice KC, Woods JH. Nonpeptidic delta-opioid receptor agonists reduce immobility in the forced swim assay in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 26: 744-55. PMID 12007745 DOI: 10.1016/S0893-133X(01)00413-4  1
2002 Ko MC, Terner J, Hursh S, Woods JH, Winger G. Relative reinforcing effects of three opioids with different durations of action. The Journal of Pharmacology and Experimental Therapeutics. 301: 698-704. PMID 11961075 DOI: 10.1124/jpet.301.2.698  1
2002 Winger G, Hursh SR, Casey KL, Woods JH. Relative reinforcing strength of three N-methyl-D-aspartate antagonists with different onsets of action. The Journal of Pharmacology and Experimental Therapeutics. 301: 690-7. PMID 11961074 DOI: 10.1124/jpet.301.2.690  1
2002 Ko MC, Naughton NN, Traynor JR, Song MS, Woods JH, Rice KC, McKnight AT. Orphanin FQ inhibits capsaicin-induced thermal nociception in monkeys by activation of peripheral ORL1 receptors. British Journal of Pharmacology. 135: 943-50. PMID 11861322 DOI: 10.1038/sj.bjp.0704535  1
2002 Koetzner L, Sumpter TL, Woods JH. Tetrabenazine fails to antagonize a behavioral effect of cocaine in rhesus monkeys. Pharmacology, Biochemistry, and Behavior. 71: 1-5. PMID 11812502 DOI: 10.1016/S0091-3057(01)00532-9  1
2002 Alt A, Clark MJ, Woods JH, Traynor JR. Mu and Delta opioid receptors activate the same G proteins in human neuroblastoma SH-SY5Y cells. British Journal of Pharmacology. 135: 217-25. PMID 11786497 DOI: 10.1038/sj.bjp.0704430  1
2001 Williams KL, Kane EC, Woods JH. Interaction of morphine and naltrexone on oral ethanol self-administration in rhesus monkeys. Behavioural Pharmacology. 12: 325-33. PMID 11710747  1
2001 Houshyar H, Galigniana MD, Pratt WB, Woods JH. Differential responsivity of the hypothalamic-pituitary-adrenal axis to glucocorticoid negative-feedback and corticotropin releasing hormone in rats undergoing morphine withdrawal: possible mechanisms involved in facilitated and attenuated stress responses. Journal of Neuroendocrinology. 13: 875-86. PMID 11679056 DOI: 10.1046/j.1365-2826.2001.00714.x  1
2001 Houshyar H, Cooper ZD, Woods JH. Paradoxical effects of chronic morphine treatment on the temperature and pituitary-adrenal responses to acute restraint stress: a chronic stress paradigm. Journal of Neuroendocrinology. 13: 862-74. PMID 11679055 DOI: 10.1046/j.1365-2826.2001.00713.x  1
2001 Woods JH. How does regulation of drug intake come about? Comment on Lynch and Carroll (2001). Experimental and Clinical Psychopharmacology. 9: 155-6; discussion 16. PMID 11518090 DOI: 10.1037/1064-1297.9.2.155  1
2001 Butelman ER, Ko MC, Traynor JR, Vivian JA, Kreek MJ, Woods JH. GR89,696: a potent kappa-opioid agonist with subtype selectivity in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 298: 1049-59. PMID 11504802  1
2001 Alt A, McFadyen IJ, Fan CD, Woods JH, Traynor JR. Stimulation of guanosine-5'-o-(3-[35S]thio)triphosphate binding in digitonin-permeabilized C6 rat glioma cells: evidence for an organized association of mu-opioid receptors and G protein. The Journal of Pharmacology and Experimental Therapeutics. 298: 116-21. PMID 11408532  1
2001 Briscoe RJ, Jeanville PM, Cabrera C, Baird TJ, Woods JH, Landry DW. A catalytic antibody against cocaine attenuates cocaine's cardiovascular effects in mice: a dose and time course analysis. International Immunopharmacology. 1: 1189-98. PMID 11407313 DOI: 10.1016/S1567-5769(01)00054-6  1
2001 Gerak LR, Woolverton WL, Nader MA, Patrick GA, Harris LS, Winger G, Woods JH, France CP. Behavioral effects of flunitrazepam: reinforcing and discriminative stimulus effects in rhesus monkeys and prevention of withdrawal signs in pentobarbital-dependent rats. Drug and Alcohol Dependence. 63: 39-49. PMID 11297830 DOI: 10.1016/S0376-8716(00)00189-7  1
2001 Winger G, Woods JH. The effects of chronic morphine on behavior reinforced by several opioids or by cocaine in rhesus monkeys. Drug and Alcohol Dependence. 62: 181-9. PMID 11295322 DOI: 10.1016/S0376-8716(00)00166-6  1
2001 Koetzner L, Deng S, Sumpter TL, Weisslitz M, Abner RT, Landry DW, Woods JH. Titer-dependent antagonism of cocaine following active immunization in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 296: 789-96. PMID 11181908  1
2000 May EL, Jacobson AE, Mattson MV, Traynor JR, Woods JH, Harris LS, Bowman ER, Aceto MD. Synthesis and in vitro and in vivo activity of (-)-(1R,5R,9R)- and (+)-(1S,5S,9S)-N-alkenyl-, -N-alkynyl-, and -N-cyanoalkyl-5, 9-dimethyl-2'-hydroxy-6,7-benzomorphan homologues. Journal of Medicinal Chemistry. 43: 5030-6. PMID 11150174 DOI: 10.1021/jm000317+  1
2000 Baird TJ, Deng SX, Landry DW, Winger G, Woods JH. Natural and artificial enzymes against cocaine. I. Monoclonal antibody 15A10 and the reinforcing effects of cocaine in rats. The Journal of Pharmacology and Experimental Therapeutics. 295: 1127-34. PMID 11082449  1
2000 Coop A, Jacobson AE, Aceto MD, Harris LS, Traynor JR, Woods JH, Rice KC. N-Cyclohexylethyl-N-noroxymorphindole: a mu-opioid preferring analogue of naltrindole. Bioorganic & Medicinal Chemistry Letters. 10: 2449-51. PMID 11078198  1
2000 Briscoe RJ, Cabrera CL, Baird TJ, Rice KC, Woods JH. Antalarmin blockade of corticotropin releasing hormone-induced hypertension in rats. Brain Research. 881: 204-7. PMID 11036160 DOI: 10.1016/S0006-8993(00)02742-6  1
2000 Jeanville PM, Woods JH, Baird TJ, Estapé ES. Direct determination of ecgonine methyl ester and cocaine in rat plasma, utilizing on-line sample extraction coupled with rapid chromatography/quadrupole orthogonal acceleration time-of-flight detection. Journal of Pharmaceutical and Biomedical Analysis. 23: 897-907. PMID 11022914 DOI: 10.1016/S0731-7085(00)00362-9  1
2000 McFadyen IJ, Houshyar H, Liu-Chen LY, Woods JH, Traynor JR. The steroid 17alpha-acetoxy-6-dimethylaminomethyl-21-fluoro-3-ethoxy-pregna-3, 5-dien-20-one (SC17599) is a selective mu-opioid agonist: implications for the mu-opioid pharmacophore. Molecular Pharmacology. 58: 669-76. PMID 10999935  1
2000 Woods JH. The next reinforcer: comment on Meisch (2000) Experimental and Clinical Psychopharmacology. 8: 360-1; discussion 36. PMID 10975626 DOI: 10.1037//1064-1297.8.3.360  1
2000 Derrick I, Neilan CL, Andes J, Husbands SM, Woods JH, Traynor JR, Lewis JW. 3-Deoxyclocinnamox: the first high-affinity, nonpeptide mu-opioid antagonist lacking a phenolic hydroxyl group. Journal of Medicinal Chemistry. 43: 3348-50. PMID 10966754 DOI: 10.1021/jm0009641  1
2000 Broom DC, Guo L, Coop A, Husbands SM, Lewis JW, Woods JH, Traynor JR. BU48: a novel buprenorphine analog that exhibits delta-opioid-mediated convulsions but not delta-opioid-mediated antinociception in mice. The Journal of Pharmacology and Experimental Therapeutics. 294: 1195-200. PMID 10945877  1
2000 Broadbear JH, Sumpter TL, Burke TF, Husbands SM, Lewis JW, Woods JH, Traynor JR. Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine. The Journal of Pharmacology and Experimental Therapeutics. 294: 933-40. PMID 10945843  1
2000 Zubieta J, Greenwald MK, Lombardi U, Woods JH, Kilbourn MR, Jewett DM, Koeppe RA, Schuster CR, Johanson CE. Buprenorphine-induced changes in mu-opioid receptor availability in male heroin-dependent volunteers: a preliminary study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 23: 326-34. PMID 10942856 DOI: 10.1016/S0893-133X(00)00110-X  1
2000 Ko MC, Willmont KJ, Burritt A, Hruby VJ, Woods JH. Local inhibitory effects of dynorphin A-(1-17) on capsaicin-induced thermal allodynia in rhesus monkeys. European Journal of Pharmacology. 402: 69-76. PMID 10940359 DOI: 10.1016/S0014-2999(00)00503-3  1
2000 Briscoe RJ, Winger G, Lewis JW, Woods JH. Methoclocinnamox: time course of changes in alfentanil-reinforced responding in rhesus monkeys. Psychopharmacology. 148: 393-9. PMID 10928312  1
2000 Williams KL, Woods JH. A behavioral economic analysis of concurrent ethanol- and water-reinforced responding in different preference conditions. Alcoholism, Clinical and Experimental Research. 24: 980-6. PMID 10924000  1
2000 Kishioka S, Paronis CA, Woods JH. Acute dependence on, but not tolerance to, heroin and morphine as measured by respiratory effects in rhesus monkeys. European Journal of Pharmacology. 398: 121-30. PMID 10856456 DOI: 10.1016/S0014-2999(00)00279-X  1
2000 Kishioka S, Ko MC, Woods JH. Diltiazem enhances the analgesic but not the respiratory depressant effects of morphine in rhesus monkeys. European Journal of Pharmacology. 397: 85-92. PMID 10844102 DOI: 10.1016/S0014-2999(00)00248-X  1
2000 Remmers AE, Clark MJ, Alt A, Medzihradsky F, Woods JH, Traynor JR. Activation of G protein by opioid receptors: role of receptor number and G-protein concentration. European Journal of Pharmacology. 396: 67-75. PMID 10822058 DOI: 10.1016/S0014-2999(00)00212-0  1
2000 Houshyar H, Mc Fadyen IJ, Woods JH, Traynor JR. Antinociceptive and other behavioral effects of the steroid SC17599 are mediated by the mu-opioid receptor. European Journal of Pharmacology. 395: 121-8. PMID 10794817 DOI: 10.1016/S0014-2999(00)00176-X  1
2000 Woods JH. Looking to the future of behavioral pharmacology while being attentive to its past. Experimental and Clinical Psychopharmacology. 8: 147-9. PMID 10743916  1
2000 Kishioka S, Paronis CA, Lewis JW, Woods JH. Buprenorphine and methoclocinnamox: agonist and antagonist effects on respiratory function in rhesus monkeys. European Journal of Pharmacology. 391: 289-97. PMID 10729371 DOI: 10.1016/S0014-2999(00)00039-X  1
2000 Ko MC, Tuchman JE, Johnson MD, Wiesenauer K, Woods JH. Local administration of mu or kappa opioid agonists attenuates capsaicin-induced thermal hyperalgesia via peripheral opioid receptors in rats. Psychopharmacology. 148: 180-5. PMID 10663433  1
2000 Derrick I, Husbands SM, Broadbear J, Traynor JR, Woods JH, Lewis JW. Cinnamoyl derivatives of 7a-amino- and 7a-(aminomethyl)- N-(cyclopropylmethyl)-6,14-endo-ethanotetrahydronororipavines are high-potency opioid antagonists Helvetica Chimica Acta. 83: 3122-3130. DOI: 10.1002/1522-2675(20001220)83:12<3122::AID-HLCA3122>3.0.CO;2-2  1
2000 May EL, Aceto MD, Bowman ER, Traynor JR, Woods JH, Jacobson AE, Harris LS. Enantiomeric (-)-(1R,5R,9R) and (+)-(1S,5S,9S) heterocyclic N-substituted-normetazocines: Synthesis of potent and selective antinociceptives and opioid antagonists through N-substituent modification Medicinal Chemistry Research. 10: 178-185.  1
1999 Patrick CA, Holden Ko MC, Woods JH. Comparison of Antinociceptive Effects Induced by Kappa Opioid Agonists in Male and Female Mice. Analgesia (Elmsford, N.Y.). 4: 397-404. PMID 21687823  0.48
1999 Vivian JA, Sumpter TL, Woods JH. Further characterization of the quinine taste discrimination stimulus in rhesus monkeys: effects of inter-trial interval, number and distribution of test stimuli. Behavioural Pharmacology. 10: 313-8. PMID 10780245  1
1999 Vivian JA, Liang YJ, Higley JD, Linnoila M, Woods JH. Oral self-administration of ethanol, phencyclidine, methadone, pentobarbital and quinine in rhesus monkeys. Psychopharmacology. 147: 113-24. PMID 10591878  1
1999 Broadbear JH, Winger G, Woods JH. Glucocorticoid-reinforced responding in the rhesus monkey. Psychopharmacology. 147: 46-55. PMID 10591868 DOI: 10.1007/s002130051141  1
1999 Ko MC, Johnson MD, Butelman ER, Willmont KJ, Mosberg HI, Woods JH. Intracisternal nor-binaltorphimine distinguishes central and peripheral kappa-opioid antinociception in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 291: 1113-20. PMID 10565831  1
1999 Traynor JR, Guo L, Coop A, Lewis JW, Woods JH. Ring-constrained orvinols as analogs of buprenorphine: differences in opioid activity related to configuration of C(20) hydroxyl group. The Journal of Pharmacology and Experimental Therapeutics. 291: 1093-9. PMID 10565829  1
1999 Neilan CL, Akil H, Woods JH, Traynor JR. Constitutive activity of the delta-opioid receptor expressed in C6 glioma cells: identification of non-peptide delta-inverse agonists. British Journal of Pharmacology. 128: 556-62. PMID 10516632 DOI: 10.1038/sj.bjp.0702816  1
1999 Williams KL, Woods JH. Naltrexone reduces ethanol- and/or water-reinforced responding in rhesus monkeys: effect depends upon ethanol concentration. Alcoholism, Clinical and Experimental Research. 23: 1462-7. PMID 10512311  1
1999 Lee KO, Akil H, Woods JH, Traynor JR. Differential binding properties of oripavines at cloned mu- and delta-opioid receptors. European Journal of Pharmacology. 378: 323-30. PMID 10493109 DOI: 10.1016/S0014-2999(99)00460-4  1
1999 Johnson MD, Ko M, Choo KS, Traynor JR, Mosberg HI, Naughton NN, Woods JH. The effects of the phyllolitorin analogue [desTrp(3), Leu(8)]phyllolitorin on scratching induced by bombesin and related peptides in rats. Brain Research. 839: 194-8. PMID 10482814 DOI: 10.1016/S0006-8993(99)01708-4  1
1999 Vivian JA, Higley JD, Linnoila M, Woods JH. Oral ethanol self-administration in rhesus monkeys: behavioral and neurochemical correlates. Alcoholism, Clinical and Experimental Research. 23: 1352-61. PMID 10470978  1
1999 Rowlett JK, Winger G, Carter RB, Wood PL, Woods JH, Woolverton WL. Reinforcing and discriminative stimulus effects of the neuroactive steroids pregnanolone and Co 8-7071 in rhesus monkeys. Psychopharmacology. 145: 205-12. PMID 10463322 DOI: 10.1007/s002130051050  1
1999 Broadbear JH, Winger G, Woods JH. Cocaine-reinforced responding in rhesus monkeys: pharmacological attenuation of the hypothalamic-pituitary-adrenal axis response. The Journal of Pharmacology and Experimental Therapeutics. 290: 1347-55. PMID 10454513  1
1999 Williams KL, Pakarinen ED, Woods JH. Quadazocine decreases responding reinforced by ethanol, sucrose, and phencyclidine fluid deliveries in rhesus monkeys: comparison to naltrexone's effects. Psychopharmacology. 144: 316-22. PMID 10435403 DOI: 10.1007/s002130051013  1
1999 Broadbear JH, Winger G, Cicero TJ, Woods JH. Effects of response contingent and noncontingent cocaine injection on hypothalamic-pituitary-adrenal activity in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 290: 393-402. PMID 10381805  1
1999 Vivian JA, DeYoung MB, Sumpter TL, Traynor JR, Lewis JW, Woods JH. kappa-Opioid receptor effects of butorphanol in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 290: 259-65. PMID 10381785  1
1999 Ko MC, Woods JH. Local administration of delta9-tetrahydrocannabinol attenuates capsaicin-induced thermal nociception in rhesus monkeys: a peripheral cannabinoid action. Psychopharmacology. 143: 322-6. PMID 10353438 DOI: 10.1007/s002130050955  1
1999 Broadbear JH, Winger G, Cicero TJ, Woods JH. Effects of self-administered cocaine on plasma adrenocorticotropic hormone and cortisol in male rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 289: 1641-7. PMID 10336563  1
1999 Butelman ER, Vivian JA, Yu J, Kreek MJ, Woods JH. Systemic effects of E-2078, a stabilized dynorphin A(1-8) analog, in rhesus monkeys. Psychopharmacology. 143: 190-6. PMID 10326782 DOI: 10.1007/s002130050935  1
1999 Williams KL, Woods JH. Conditioned effects produced by naltrexone doses that reduce ethanol-reinforced responding in rhesus monkeys. Alcoholism, Clinical and Experimental Research. 23: 708-15. PMID 10235307 DOI: 10.1097/00000374-199904001-00018  1
1999 Woolverton WL, Rowlett JK, Winger G, Woods JH, Gerak LR, France CP. Evaluation of the reinforcing and discriminative stimulus effects of gamma-hydroxybutyrate in rhesus monkeys. Drug and Alcohol Dependence. 54: 137-43. PMID 10217553 DOI: 10.1016/S0376-8716(98)00153-7  1
1999 Campbell CM, Butelman ER, Woods JH. Effects of (+)-HA-966, CGS-19755, phencyclidine, and dizocilpine on repeated acquisition of response chains in pigeons: systemic manipulation of central glycine sites. The Journal of Pharmacology and Experimental Therapeutics. 289: 521-7. PMID 10087045  1
1999 Ko MC, Butelman ER, Woods JH. Activation of peripheral kappa opioid receptors inhibits capsaicin-induced thermal nociception in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 289: 378-85. PMID 10087027  1
1999 Aspen J, Gatch MB, Woods JH. Training and characterization of a quinine taste discrimination in rhesus monkeys. Psychopharmacology. 141: 251-7. PMID 10027506 DOI: 10.1007/s002130050832  1
1999 Remmers AE, Clark MJ, Mansour A, Akil H, Woods JH, Medzihradsky F. Opioid efficacy in a C6 glioma cell line stably expressing the human kappa opioid receptor. The Journal of Pharmacology and Experimental Therapeutics. 288: 827-33. PMID 9918595  1
1999 Pakarinen ED, Williams KL, Woods JH. Food restriction and sex differences on concurrent, oral ethanol and water reinforcers in juvenile rhesus monkeys. Alcohol (Fayetteville, N.Y.). 17: 35-40. PMID 9895035 DOI: 10.1016/S0741-8329(98)00030-5  1
1998 Williams KL, Woods JH. Oral ethanol-reinforced responding in rhesus monkeys: effects of opioid antagonists selective for the mu-, kappa-, or delta-receptor. Alcoholism, Clinical and Experimental Research. 22: 1634-9. PMID 9835275  1
1998 Williams KL, Winger G, Pakarinen ED, Woods JH. Naltrexone reduces ethanol- and sucrose-reinforced responding in rhesus monkeys. Psychopharmacology. 139: 53-61. PMID 9768542  0.84
1998 Husbands SM, Sadd J, Broadbear JH, Woods JH, Martin J, Traynor JR, Aceto MD, Bowman ER, Harris LS, Lewis JW. 3-Alkyl ethers of clocinnamox: delayed long-term mu-antagonists with variable mu efficacy. Journal of Medicinal Chemistry. 41: 3493-8. PMID 9719602 DOI: 10.1021/jm9810248  1
1998 Lieberman PB, Woods JH, Young EA. The role of endogenous opioids in the luteinizing hormone surge in rats: studies with clocinnamox, a long-lasting opioid receptor antagonist. European Journal of Pharmacology. 352: 73-9. PMID 9718270 DOI: 10.1016/S0014-2999(98)00341-0  1
1998 Mets B, Winger G, Cabrera C, Seo S, Jamdar S, Yang G, Zhao K, Briscoe RJ, Almonte R, Woods JH, Landry DW. A catalytic antibody against cocaine prevents cocaine's reinforcing and toxic effects in rats. Proceedings of the National Academy of Sciences of the United States of America. 95: 10176-81. PMID 9707620  0.84
1998 Vivian JA, Kishioka S, Butelman ER, Broadbear J, Lee KO, Woods JH. Analgesic, respiratory and heart rate effects of cannabinoid and opioid agonists in rhesus monkeys: antagonist effects of SR 141716A. The Journal of Pharmacology and Experimental Therapeutics. 286: 697-703. PMID 9694923  0.68
1998 France CP, Gerak LR, Rowlett JK, Woolverton WL, Winger G, Woods JH. Progress report from the testing program for stimulant and depressant drugs (1996). Nida Research Monograph. 178: 429-39. PMID 9686406  1
1998 Woods JH, Medzihradsky F, Smith CB, Winger G, Traynor JR. Evaluation of new compounds for opioid activity (1997). Nida Research Monograph. 178: 408-28. PMID 9686405  1
1998 Alt A, Mansour A, Akil H, Medzihradsky F, Traynor JR, Woods JH. Stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding by endogenous opioids acting at a cloned mu receptor. The Journal of Pharmacology and Experimental Therapeutics. 286: 282-8. PMID 9655870  1
1998 Ko MC, Butelman ER, Woods JH. The role of peripheral mu opioid receptors in the modulation of capsaicin-induced thermal nociception in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 286: 150-6. PMID 9655854  0.68
1998 Butelman ER, Ko MC, Sobczyk-Kojiro K, Mosberg HI, Van Bemmel B, Zernig G, Woods JH. kappa-Opioid receptor binding populations in rhesus monkey brain: relationship to an assay of thermal antinociception. The Journal of Pharmacology and Experimental Therapeutics. 285: 595-601. PMID 9580603  1
1998 Ko MC, Butelman ER, Traynor JR, Woods JH. Differentiation of kappa opioid agonist-induced antinociception by naltrexone apparent pA2 analysis in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 285: 518-26. PMID 9580592  1
1998 Elmer GI, Pieper JO, Negus SS, Woods JH. Genetic variance in nociception and its relationship to the potency of morphine-induced analgesia in thermal and chemical tests. Pain. 75: 129-40. PMID 9539682 DOI: 10.1016/S0304-3959(97)00215-7  1
1998 Vanecek SA, Essman WD, Taylor DP, Woods JH. Discriminative stimulus characteristics of BMY 14802 in the pigeon. The Journal of Pharmacology and Experimental Therapeutics. 284: 1-9. PMID 9435153  1
1997 Clark MJ, Emmerson PJ, Mansour A, Akil H, Woods JH, Portoghese PS, Remmers AE, Medzihradsky F. Opioid efficacy in a C6 glioma cell line stably expressing the delta opioid receptor. The Journal of Pharmacology and Experimental Therapeutics. 283: 501-10. PMID 9353363  1
1997 Yu J, Butelman ER, Woods JH, Chait BT, Kreek MJ. Dynorphin A (1-8) analog, E-2078, crosses the blood-brain barrier in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 282: 633-8. PMID 9262324  0.68
1997 Woods JH, Winger G. Abuse liability of flunitrazepam. Journal of Clinical Psychopharmacology. 17: 1S-57S. PMID 9169981  0.84
1997 Zernig G, Lewis JW, Woods JH. Clocinnamox inhibits the intravenous self-administration of opioid agonists in rhesus monkeys: comparison with effects on opioid agonist-mediated antinociception. Psychopharmacology. 129: 233-42. PMID 9084061  0.52
1997 Yu J, Butelman ER, Woods JH, Chait BT, Kreek MJ. Dynorphin A (1-8) analog, E-2078, is stable in human and rhesus monkey blood. The Journal of Pharmacology and Experimental Therapeutics. 280: 1147-51. PMID 9067297  0.68
1996 Winger G, Woods JH. Effects of buprenorphine on behaviour maintained by heroin and alfentanil in rhesus monkeys. Behavioural Pharmacology. 7: 155-159. PMID 11224407  0.84
1996 Butelman ER, Lewis JW, Woods JH. Methoclocinnamox: agonist and antagonist effects of a novel long-lasting opioid in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 279: 934-8. PMID 8930202  0.68
1996 Yu J, Butelman ER, Woods JH, Chait BT, Kreek MJ. In vitro biotransformation of dynorphin A (1-17) is similar in human and rhesus monkey blood as studied by matrix-assisted laser desorption/ionization mass spectrometry. The Journal of Pharmacology and Experimental Therapeutics. 279: 507-14. PMID 8930152  0.68
1996 Jewett DC, Mosberg HI, Woods JH. Discriminative stimulus effects of a centrally administered, delta-opioid peptide (D-Pen2-D-Pen5-enkephalin) in pigeons. Psychopharmacology. 127: 225-30. PMID 8912400 DOI: 10.1007/s002130050080  1
1996 Acteo MD, Bowman E, Butelman E, Englis JA, Harrish L, Jacobson AE, Mattson MV, Medzihradsky F, Patrick G, Rowlett JK, Smith CB, Winger G, Woods JH, Woolverton WL. Zipeprol: preclinical assessment of abuse potential. Drug and Alcohol Dependence. 42: 93-104. PMID 8889408 DOI: 10.1016/0376-8716(96)01267-7  1
1996 Butelman ER, Negus SS, Lewis JW, Woods JH. Clocinnamox antagonism of opioid suppression of schedule-controlled responding in rhesus monkeys. Psychopharmacology. 123: 320-4. PMID 8867870  0.68
1996 Zernig G, Burke T, Lewis JW, Woods JH. Mechanism of clocinnamox blockade of opioid receptors: evidence from in vitro and ex vivo binding and behavioral assays. The Journal of Pharmacology and Experimental Therapeutics. 279: 23-31. PMID 8858971  0.52
1996 Zernig G, Issaevitch T, Woods JH. Calculation of agonist efficacy, apparent affinity, and receptor population changes after administration of insurmountable antagonists: comparison of different analytical approaches. Journal of Pharmacological and Toxicological Methods. 35: 223-37. PMID 8823669  0.52
1996 Emmerson PJ, Clark MJ, Mansour A, Akil H, Woods JH, Medzihradsky F. Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor. The Journal of Pharmacology and Experimental Therapeutics. 278: 1121-7. PMID 8819494  0.72
1996 Jewett DC, Butelman ER, Woods JH. Nitric oxide synthase inhibitors produce phencyclidine-like behavioral effects in pigeons. Brain Research. 715: 25-31. PMID 8739619 DOI: 10.1016/0006-8993(95)01328-8  0.68
1995 Jewett DC, Woods JH. Nor-binaltorphimine: an ultra-long acting kappa-opioid antagonist in pigeons. Behavioural Pharmacology. 6: 815-820. PMID 11224385  0.52
1995 Woods JH, Lewis JW, Winger G, Butelman E, Broadbear J, Zernig G. Methoclocinnamox: a mu partial agonist with pharmacotherapeutic potential for heroin abuse. Nida Research Monograph. 147: 195-219. PMID 8742788  0.84
1995 Butelman ER, Winger G, Zernig G, Woods JH. Butorphanol: characterization of agonist and antagonist effects in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 272: 845-53. PMID 7853203  0.84
1995 Pakarinen ED, Woods JH, Moerschbaecher JM. Repeated acquisition of behavioral chains in squirrel monkeys: comparisons of a mu, kappa and delta opioid agonist. The Journal of Pharmacology and Experimental Therapeutics. 272: 552-9. PMID 7853168  1
1995 Walker EA, Zernig G, Woods JH. Buprenorphine antagonism of mu opioids in the rhesus monkey tail-withdrawal procedure. The Journal of Pharmacology and Experimental Therapeutics. 273: 1345-52. PMID 7791107  1
1995 Negus SS, Butelman ER, Gatch MB, Woods JH. Effects of morphine and ketorolac on thermal allodynia induced by prostaglandin E2 and bradykinin in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 274: 805-14. PMID 7636744  0.68
1995 Woods JH, Winger G. Current benzodiazepine issues. Psychopharmacology. 118: 107-15; discussion 1. PMID 7617794  0.84
1995 France CP, Gerak LR, Flynn D, Winger GD, Medzihradsky F, Bagley JR, Brockunier LL, Woods JH. Behavioral effects and receptor binding affinities of fentanyl derivatives in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 274: 17-28. PMID 7616395  1
1995 Butelman ER, France CP, Woods JH. Agonist and antagonist effects of dynorphin A-(1-13) in a thermal antinociception assay in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 275: 374-80. PMID 7562573  1
1995 Butelman ER, Negus SS, Gatch MB, Chang KJ, Woods JH. BW373U86, a delta-opioid receptor agonist, reverses bradykinin-induced thermal allodynia in rhesus monkeys. European Journal of Pharmacology. 277: 285-7. PMID 7493622  0.68
1995 Zernig G, Issaevitch T, Broadbear JH, Burke TF, Lewis JW, Brine GA, Woods JH. Receptor reserve and affinity of mu opioid agonists in mouse antinociception: correlation with receptor binding. Life Sciences. 57: 2113-25. PMID 7475964  0.52
1994 Takasuna M, Negus SS, DeCosta BR, Woods JH. Opioid pharmacology of the antinociceptive effects of loperamide in mice. Behavioural Pharmacology. 5: 189-195. PMID 11224267  0.6
1994 Patrick GA, Harris LS, Woolverton WL, Nader MA, Winger G, Woods JH. Progress report from the testing program for stimulant and depressant drugs (1993). Nida Research Monograph. 140: 248-63. PMID 8722467  1
1994 Woods JH, France CP, Medzihradsky F, Smith CB, Winger GD. Evaluation of new compounds for opioid activity annual report (1993). Nida Research Monograph. 140: 196-247. PMID 8722466  1
1994 France CP, Medzihradsky F, Woods JH. Comparison of kappa opioids in rhesus monkeys: behavioral effects and receptor binding affinities. The Journal of Pharmacology and Experimental Therapeutics. 268: 47-58. PMID 8301589  1
1994 Zernig G, Butelman ER, Lewis JW, Walker EA, Woods JH. In vivo determination of mu opioid receptor turnover in rhesus monkeys after irreversible blockade with clocinnamox. The Journal of Pharmacology and Experimental Therapeutics. 269: 57-65. PMID 8169852  1
1994 Emmerson PJ, Liu MR, Woods JH, Medzihradsky F. Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes. The Journal of Pharmacology and Experimental Therapeutics. 271: 1630-7. PMID 7996478  0.72
1994 Gerak LR, Butelman ER, Woods JH, France CP. Antinociceptive and respiratory effects of nalbuphine in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 271: 993-9. PMID 7965822  1
1994 Burke TF, Woods JH, Lewis JW, Medzihradsky F. Irreversible opioid antagonist effects of clocinnamox on opioid analgesia and mu receptor binding in mice. The Journal of Pharmacology and Experimental Therapeutics. 271: 715-21. PMID 7965787  1
1994 Negus SS, Butelman ER, Chang KJ, DeCosta B, Winger G, Woods JH. Behavioral effects of the systemically active delta opioid agonist BW373U86 in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 270: 1025-34. PMID 7932149  0.84
1994 Broadbear JH, Negus SS, Butelman ER, de Costa BR, Woods JH. Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on kappa-opioid agonists in the mouse writhing assay. Psychopharmacology. 115: 311-9. PMID 7871070  0.84
1993 France CP, Woods JH. U-50, 488, saline and naltrexone discrimination in U-50, 488-treated pigeons. Behavioural Pharmacology. 4: 509-516. PMID 11224218  1
1993 Baron SP, Butelman ER, Woods JH. Discriminative stimulus effects of NMDA in pigeons and monkeys. Behavioural Pharmacology. 4: 115-123. PMID 11224178  0.68
1993 Butelman ER, Baron SP, Woods JH. Ethanol effects in pigeons trained to discriminate MK-801, PCP or CGS-19755. Behavioural Pharmacology. 4: 57-60. PMID 11224171  0.68
1993 Woods JH, France CP, Medzihradsky F, Smith CB, Winger GD. Evaluation of new compounds for opioid activity, 1992. Nida Research Monograph. 132: 517-78. PMID 8393529  1
1993 Negus SS, Butelman ER, Al Y, Woods JH. Prostaglandin E2-induced thermal hyperalgesia and its reversal by morphine in the warm-water tail-withdrawal procedure in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 266: 1355-63. PMID 8371142  0.68
1993 Skjoldager P, Winger G, Woods JH. Effects of GBR 12909 and cocaine on cocaine-maintained behavior in rhesus monkeys. Drug and Alcohol Dependence. 33: 31-9. PMID 8370338  0.84
1993 Butelman ER, Negus SS, Ai Y, de Costa BR, Woods JH. Kappa opioid antagonist effects of systemically administered nor-binaltorphimine in a thermal antinociception assay in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 267: 1269-76. PMID 8263790  0.84
1993 Negus SS, Burke TF, Medzihradsky F, Woods JH. Effects of opioid agonists selective for mu, kappa and delta opioid receptors on schedule-controlled responding in rhesus monkeys: antagonism by quadazocine. The Journal of Pharmacology and Experimental Therapeutics. 267: 896-903. PMID 8246165  0.72
1993 Comer SD, Hoenicke EM, Sable AI, McNutt RW, Chang KJ, De Costa BR, Mosberg HI, Woods JH. Convulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice. The Journal of Pharmacology and Experimental Therapeutics. 267: 888-95. PMID 8246164  1
1993 Comer SD, McNutt RW, Chang KJ, De Costa BR, Mosberg HI, Woods JH. Discriminative stimulus effects of BW373U86: a nonpeptide ligand with selectivity for delta opioid receptors. The Journal of Pharmacology and Experimental Therapeutics. 267: 866-74. PMID 8246161  1
1993 Woolverton WL, Nader MA, Winger G, Woods JH, Patrick GA, Harris LS. Progress report from the testing program for stimulant and depressant drug (1992). Nida Research Monograph. 132: 579-94. PMID 8101976  1
1993 Butelman ER, Woods JH. Effects of clonidine, dexmedetomidine and xylazine on thermal antinociception in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 264: 762-9. PMID 8094751  0.68
1993 Butelman ER, France CP, Woods JH. Apparent pA2 analysis on the respiratory depressant effects of alfentanil, etonitazene, ethylketocyclazocine (EKC) and Mr2033 in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 264: 145-51. PMID 8093721  1
1993 Walker EA, Butelman ER, DeCosta BR, Woods JH. Opioid thermal antinociception in rhesus monkeys: receptor mechanisms and temperature dependency. The Journal of Pharmacology and Experimental Therapeutics. 267: 280-6. PMID 7901396  1
1992 France CP, Woods JH. Naloxone benzylhydrazone is a µ-selective opioid antagonist without kappa agonist effects in rhesus monkeys. Behavioural Pharmacology. 3: 133-141. PMID 11224111  1
1992 Winger G, Skjoldager P, Woods JH. Effects of buprenorphine and other opioid agonists and antagonists on alfentanil- and cocaine-reinforced responding in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 261: 311-7. PMID 1560376  0.84
1992 Woods JH, Winger G, France CP. Use of in vivo apparent pA2 analysis in assessment of opioid abuse liability. Trends in Pharmacological Sciences. 13: 282-6. PMID 1509522 DOI: 10.1016/0165-6147(92)90086-L  1
1992 Woods JH, Medzihradsky F, Smith CB, Winger GD, France CP. Evaluation of new compounds for opioid activity (1991). Nida Research Monograph. 119: 559-603. PMID 1435986  1
1992 Lu Y, France CP, Woods JH. Tolerance to the cataleptic effect of the N-methyl-D-aspartate (NMDA) receptor antagonists in pigeons: cross-tolerance between PCP-like compounds and competitive NMDA antagonists. The Journal of Pharmacology and Experimental Therapeutics. 263: 499-504. PMID 1432686  1
1992 Woods JH, France CP, Winger GD. Behavioral pharmacology of buprenorphine: issues relevant to its potential in treating drug abuse. Nida Research Monograph. 121: 12-27. PMID 1406907  1
1992 France CP, Winger G, Seggel MR, Rice KC, Woods JH. Pharmacological profile of a potent, efficacious fentanyl derivative in rhesus monkeys. Psychopharmacology. 109: 291-8. PMID 1365629 DOI: 10.1007/BF02245876  1
1992 Winger G, Woods JH, Patrick GA, Powell LJ, Harris LS, Nader MA, Woolverton WL. Progress report from the Testing Program for Stimulant and Depressant Drugs (1991). Nida Research Monograph. 119: 625-39. PMID 1359421  1
1992 Patrick GA, Harris LS, Nader MA, Woolverton WL, Winger G, Woods JH. Progress report from the Testing Program for Stimulant and Depressant Drugs (1990). Nida Research Monograph. 119: 604-24. PMID 1359420  1
1992 Woods JH, Katz JL, Winger G. Benzodiazepines: use, abuse, and consequences. Pharmacological Reviews. 44: 151-347. PMID 1356276  0.96
1992 Bertalmio AJ, Woods JH. Discriminative stimulus effects of cyclorphan: selective antagonism with naltrexone. Psychopharmacology. 106: 189-94. PMID 1347952  0.48
1992 Winger G, France CP, Woods JH, Smith CB, Medzihradsky F, Iorio MA. Opioid and non-opioid effects of novel butyrophenone analogues. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 7: 177-87. PMID 1326980  1
1992 Comer SD, Burke TF, Lewis JW, Woods JH. Clocinnamox: a novel, systemically-active, irreversible opioid antagonist. The Journal of Pharmacology and Experimental Therapeutics. 262: 1051-6. PMID 1326622  1
1992 Bertalmio AJ, Medzihradsky F, Winger G, Woods JH. Differential influence of N-dealkylation on the stimulus properties of some opioid agonists. The Journal of Pharmacology and Experimental Therapeutics. 261: 278-84. PMID 1313871  0.84
1991 Butelman ER, France CP, Woods JH. The discriminative stimulus effects of MK-801 in pigeons. Behavioural Pharmacology. 2: 79-86. PMID 11224051  1
1991 France CP, Moerschbaecher JM, Woods JH. MK-801 and related compounds in monkeys: discriminative stimulus effects and effects on a conditional discrimination. The Journal of Pharmacology and Experimental Therapeutics. 257: 727-34. PMID 2033515  1
1991 Nader MA, Winger G, Woods JH, Woolverton WL. Discriminative and reinforcing effects of brotizolam in rhesus monkeys. Psychopharmacology. 103: 166-71. PMID 2027918 DOI: 10.1007/BF02244198  1
1991 Skjoldager P, Winger G, Woods JH. Analysis of fixed-ratio behavior maintained by drug reinforcers. Journal of the Experimental Analysis of Behavior. 56: 331-43. PMID 1955820 DOI: 10.1901/jeab.1991.56-331  0.84
1991 Walker EA, Yamamoto T, Hollingsworth PJ, Smith CB, Woods JH. Discriminative-stimulus effects of quipazine and l-5-hydroxytryptophan in relation to serotonin binding sites in the pigeon. The Journal of Pharmacology and Experimental Therapeutics. 259: 772-82. PMID 1941625  1
1991 Yamamoto T, Walker EA, Woods JH. Agonist and antagonist properties of serotonergic compounds in pigeons trained to discriminate either quipazine or L-5-hydroxytryptophan. The Journal of Pharmacology and Experimental Therapeutics. 258: 999-1007. PMID 1890629  1
1991 Woods JH, Katz JL, Winger GD. Restricting benzodiazepine prescribing. Lancet. 337: 295. PMID 1671128  0.96
1991 France CP, Winger G, Medzihradsky F, Seggel MR, Rice KC, Woods JH. Mirfentanil: pharmacological profile of a novel fentanyl derivative with opioid and nonopioid effects. The Journal of Pharmacology and Experimental Therapeutics. 258: 502-10. PMID 1650830  1
1991 Comer SD, France CP, Woods JH. Training dose: influences in opioid drug discrimination. Nida Research Monograph. 145-61. PMID 1369665  1
1990 France CP, Woods JH. Discriminative stimulus effects of opioid agonists in morphine-dependent pigeons. The Journal of Pharmacology and Experimental Therapeutics. 254: 626-32. PMID 2384889  1
1990 Thurkauf A, de Costa B, Mattson MV, France CP, Price MT, Olney JW, Woods JH, Jacobson AE, Rice KC. Synthesis, phencyclidine-like pharmacology, and antiischemic potential of meta-substituted 1-(1-phenylcyclohexyl)-1,2,3,6-tetrahydropyridines. Journal of Medicinal Chemistry. 33: 2211-5. PMID 2374147  1
1990 France CP, Lu Y, Woods JH. Interactions between N-methyl-D-aspartate and CGS 19755 administered intramuscularly and intracerebroventricularly in pigeons. The Journal of Pharmacology and Experimental Therapeutics. 255: 1271-7. PMID 2262905  1
1990 France CP, Winger GD, Woods JH. Analgesic, anesthetic, and respiratory effects of the competitive N-methyl-D-aspartate (NMDA) antagonist CGS 19755 in rhesus monkeys. Brain Research. 526: 355-8. PMID 2257491 DOI: 10.1016/0006-8993(90)91247-E  1
1990 Koek W, Woods JH, Colpaert FC. N-methyl-D-aspartate antagonism and phencyclidine-like activity: a drug discrimination analysis. The Journal of Pharmacology and Experimental Therapeutics. 253: 1017-25. PMID 2193142  0.72
1990 France CP, de Costa BR, Jacobson AE, Rice KC, Woods JH. Apparent affinity of opioid antagonists in morphine-treated rhesus monkeys discriminating between saline and naltrexone. The Journal of Pharmacology and Experimental Therapeutics. 252: 600-4. PMID 2156055  1
1990 France CP, Woods JH. Respiratory effects of receptor-selective opioids in rhesus monkeys. Progress in Clinical and Biological Research. 328: 295-8. PMID 2154784  1
1990 Woods JH, Medzihradsky F, Smith CB, Winger GD, France CP. Evaluation of new compounds for opioid activity (1990). Nida Research Monograph. 105: 682-724. PMID 1876152  1
1988 Woods JH, Bertalmio AJ, Young AM, Essman WD, Winger G. Receptor mechanisms of opioid drug discrimination. Psychopharmacology Series. 4: 95-106. PMID 2839823  1
1984 Herling S, Valentino RJ, Solomon RE, Woods JH. Narcotic discrimination in pigeons: antagonism by naltrexone. European Journal of Pharmacology. 105: 137-42. PMID 6386494 DOI: 10.1016/0014-2999(84)90657-5  1
1984 Young AM, Stephens KR, Hein DW, Woods JH. Reinforcing and discriminative stimulus properties of mixed agonist-antagonist opioids. The Journal of Pharmacology and Experimental Therapeutics. 229: 118-26. PMID 6142942  1
1983 Valentino RJ, Herling S, Woods JH. Discriminative stimulus effects of naltrexone in narcotic-naive and morphine-treated pigeons. The Journal of Pharmacology and Experimental Therapeutics. 224: 307-13. PMID 6681632  1
1983 Valentino RJ, Katz JL, Medzihradsky F, Woods JH. Receptor binding, antagonist, and withdrawal precipitating properties of opiate antagonists. Life Sciences. 32: 2887-96. PMID 6304445 DOI: 10.1016/0024-3205(83)90325-9  1
1983 Woods JH, Young AM, Medzihradsky F, Smith CB, Aceto MD, Harris LS, Jacobson AE. Zomepirac: preclinical narcotic abuse liability evaluation. Arzneimittel-Forschung. 33: 218-22. PMID 6133523  1
1982 Falk JL, Schuster CR, Bigelow GE, Woods JH. Progress and needs in the experimental analysis of drug and alcohol dependence. The American Psychologist. 37: 1124-7. PMID 7149427 DOI: 10.1037/0003-066X.37.10.1124  1
1982 Young AM, Woods JH. Limitations on the antagonistic actions of opioid antagonists. Federation Proceedings. 41: 2333-8. PMID 7042396  1
1982 Woods JH, Young AM, Herling S. Classification of narcotics on the basis of their reinforcing, discriminative, and antagonist effects in rhesus monkeys. Federation Proceedings. 41: 221-7. PMID 7037459  1
1982 Woods JH, Katz JL, Medzihradsky F, Smith CB, Young AM, Winger GD. 1981 annual report: evaluation of new compounds for opioid activity. Nida Research Monograph. 41: 381-451. PMID 6811931  1
1982 Herling S, Hein DW, Nemeth MA, Valentino RJ, Woods JH. Discriminative stimulus, antagonist, and rate-decreasing effects of cyclorphan: multiple modes of action. Life Sciences. 30: 331-41. PMID 6122153 DOI: 10.1016/0024-3205(82)90569-0  1
1981 Young AM, Woods JH. Maintenance of behavior by ketamine and related compounds in rhesus monkeys with different self-administration histories. The Journal of Pharmacology and Experimental Therapeutics. 218: 720-7. PMID 7264955  1
1981 Woods JH, Schuster CR, Hartel CR. Behavioral effects of thebaine in the rhesus monkey. Pharmacology, Biochemistry, and Behavior. 14: 805-9. PMID 7255516 DOI: 10.1016/0091-3057(81)90364-6  1
1981 Valentino RJ, Herling S, Woods JH. The relationship between the acute behavioral effects of narcotic antagonists and the narcotic-dependent state [proceedings]. Psychopharmacology Bulletin. 17: 51-4. PMID 7195052  1
1981 Valentino RJ, Smith CB, Woods JH. Physiological and behavioral approaches to the study of the quasi-morphine withdrawal syndrome. Federation Proceedings. 40: 1502-7. PMID 7194193  1
1981 Hein DW, Young AM, Herling S, Woods JH. Pharmacological analysis of the discriminative stimulus characteristics of ethylketazocine in the rhesus monkey. The Journal of Pharmacology and Experimental Therapeutics. 218: 7-15. PMID 7017107  1
1981 Young AM, Herling S, Woods JH. History of drug exposure as a determinant of drug self-administration. Nida Research Monograph. 37: 75-88. PMID 6798469  1
1981 Young AM, Swain HH, Woods JH. Comparison of opioid agonists in maintaining responding and in suppressing morphine withdrawal in rhesus monkeys. Psychopharmacology. 74: 329-35. PMID 6794076 DOI: 10.1007/BF00432741  1
1981 Woods JH, Medzihradsky F, Smith CB, Young AM, Swain HH. Annual report: evaluation of new compounds for opioid activity (1980). Nida Research Monograph. 34: 327-66. PMID 6783945  1
1981 Young AM, Herling S, Winger GD, Woods JH. Comparison of discriminative and reinforcing effects of ketamine and related compounds in the rhesus monkey. Nida Research Monograph. 34: 173-9. PMID 6783928  1
1981 Young AM, Katz JL, Woods JH. Behavioral effects of levonantradol and nantradol in the rhesus monkey. Journal of Clinical Pharmacology. 21: 348S-360S. PMID 6271836  1
1981 Valentino RJ, Herling S, Woods JH, Medzihradsky F, Merz H. Quaternary naltrexone: evidence for the central mediation of discriminative stimulus effects of narcotic agonists and antagonists. The Journal of Pharmacology and Experimental Therapeutics. 217: 652-9. PMID 6262493  1
1981 Woods JH, Katz JL, Young AM, Medzihradsky F, Smith CB. Correlations among certain behavioral, physiological, and biochemical effects of narcotic agonists. Nida Research Monograph. 34: 43-57. PMID 6261136  1
1980 Herling S, Coale EH, Valentino RJ, Hein DW, Woods JH. Narcotic discrimination in pigeons. The Journal of Pharmacology and Experimental Therapeutics. 214: 139-46. PMID 6993656  1
1980 Young AM, Woods JH. Behavior maintained by intravenous injection of codeine, cocaine, and etorphine in the rhesus macaque and the pigtail macaque. Psychopharmacology. 70: 263-71. PMID 6777798 DOI: 10.1007/BF00427883  1
1979 Valentino RJ, Smith CB, Woods JH. An unusual benzazocine elicits acetylcholine release in the isolated guinea pig ileum. Nature. 281: 370-2. PMID 225676 DOI: 10.1038/281370a0  1
1979 Woods JH, Herling S, Valentino RJ, Hein DW, Coale EH. Narcotic drug discriminations by rhesus monkeys and pigeons. Nida Research Monograph. 27: 128-34. PMID 121328  1
1978 Tessel RE, Woods JH. meta Substituted N-ethylamphetamine self injection responding in the rhesus monkey: structure-activity relationships. The Journal of Pharmacology and Experimental Therapeutics. 205: 274-81. PMID 417172  1
1975 Tessel RE, Woods JH, Counsell RE, Basmadjian GP. Structure-activity relationships between meta-substituted N-ethylamphetamines and isolated guinea-pig atrial rate. The Journal of Pharmacology and Experimental Therapeutics. 192: 319-26. PMID 1117419  1
1975 Tessel RE, Woods JH, Counsell RE, Lu M. Structure-activity relationships between meta-substituted N-ethylamphetamines and locomotor activity in mice. The Journal of Pharmacology and Experimental Therapeutics. 192: 310-8. PMID 1117418  1
1975 Winger G, Stitzer ML, Woods JH. Barbiturate-reinforced responding in rhesus monkeys: comparisons of drugs with different durations of action. The Journal of Pharmacology and Experimental Therapeutics. 195: 505-14. PMID 811787  0.84
1975 Tessel RE, Woods JH. Fenfluramine and N-ethyl amphetamine: comparison of the reinforcing and rate-decreasing actions in the rhesus monkey. Psychopharmacologia. 43: 239-44. PMID 810821 DOI: 10.1007/BF00429257  1
1974 Woods JH, Tessel RE. Fenfluramine: amphetamine congener that fails to maintain drug-taking behavior in the rhesus monkey. Science (New York, N.Y.). 185: 1067-9. PMID 4212011  1
1971 Goldberg SR, Woods JH, Schuster CR. Nalorphine-induced changes in morphine self-administration in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 176: 464-71. PMID 4998693  1
1969 Goldberg SR, Woods JH, Schuster CR. Morphine: conditioned increases in self-administration in rhesus monkeys. Science (New York, N.Y.). 166: 1306-7. PMID 4981723  1
1966 Schuster CR, Dockens WS, Woods JH. Behavioral variables affecting the development of amphetamine tolerance. Psychopharmacologia. 9: 170-82. PMID 5983915  1
1966 Schuster CR, Woods JH. Schedule-induced polydipsia in the rhesus monkey. Psychological Reports. 19: 823-8. PMID 4963005 DOI: 10.2466/pr0.1966.19.3.823  1
Show low-probability matches.